Jordan H. Salas
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
Salas, Jordan H.; Urbanowicz, Richard A.; Guest, Johnathan D.; Frumento, Nicole; Figueroa, Alexis; Clark, Kaitlyn E.; Keck, Zhenyong; Cowton, Vanessa M.; Cole, Sarah J.; Patel, Arvind H.; Fuerst, Thomas R.; Drummer, Heidi E.; Major, Marian; Tarr, Alexander W.; Ball, Jonathan K.; Law, Mansun; Pierce, Brian G.; Foung, Steven K.H.; Bailey, Justin R.
Authors
Richard A. Urbanowicz
Johnathan D. Guest
Nicole Frumento
Alexis Figueroa
Kaitlyn E. Clark
Zhenyong Keck
Vanessa M. Cowton
Sarah J. Cole
Arvind H. Patel
Thomas R. Fuerst
Heidi E. Drummer
Marian Major
ALEXANDER TARR alex.tarr@nottingham.ac.uk
Associate Professor
JONATHAN BALL jonathan.ball@nottingham.ac.uk
Professor of Molecular Virology
Mansun Law
Brian G. Pierce
Steven K.H. Foung
Justin R. Bailey
Abstract
Background & Aims: Development of a prophylactic hepatitis C virus (HCV) vaccine will require accurate and reproducible measurement of neutralizing breadth of vaccine-induced antibodies. Currently available HCV panels may not adequately represent the genetic and antigenic diversity of circulating HCV strains, and the lack of standardization of these panels makes it difficult to compare neutralization results obtained in different studies. Here, we describe the selection and validation of a genetically and antigenically diverse reference panel of 15 HCV pseudoparticles (HCVpps) for neutralization assays. Methods: We chose 75 envelope (E1E2) clones to maximize representation of natural polymorphisms observed in circulating HCV isolates, and 65 of these clones generated functional HCVpps. Neutralization sensitivity of these HCVpps varied widely. HCVpps clustered into 15 distinct groups based on patterns of relative sensitivity to 7 broadly neutralizing monoclonal antibodies. We used these data to select a final panel of 15 antigenically representative HCVpps. Results: Both the 65 and 15 HCVpp panels span 4 tiers of neutralization sensitivity, and neutralizing breadth measurements for 7 broadly neutralizing monoclonal antibodies were nearly equivalent using either panel. Differences in neutralization sensitivity between HCVpps were independent of genetic distances between E1E2 clones. Conclusions: Neutralizing breadth of HCV antibodies should be defined using viruses spanning multiple tiers of neutralization sensitivity rather than panels selected solely for genetic diversity. We propose that this multitier reference panel could be adopted as a standard for the measurement of neutralizing antibody potency and breadth, facilitating meaningful comparisons of neutralization results from vaccine studies in different laboratories.
Citation
Salas, J. H., Urbanowicz, R. A., Guest, J. D., Frumento, N., Figueroa, A., Clark, K. E., …Bailey, J. R. (2022). An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development. Gastroenterology, 162(2), 562-574. https://doi.org/10.1053/j.gastro.2021.10.005
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 6, 2021 |
Online Publication Date | Oct 13, 2021 |
Publication Date | Feb 1, 2022 |
Deposit Date | Nov 9, 2022 |
Publicly Available Date | Nov 9, 2022 |
Journal | Gastroenterology |
Print ISSN | 0016-5085 |
Electronic ISSN | 1528-0012 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 162 |
Issue | 2 |
Pages | 562-574 |
DOI | https://doi.org/10.1053/j.gastro.2021.10.005 |
Keywords | Hepatitis C Virus; Broadly Neutralizing Antibodies; Neutralizing Breadth; Vaccine |
Public URL | https://nottingham-repository.worktribe.com/output/7171775 |
Publisher URL | https://www.gastrojournal.org/article/S0016-5085(21)03624-6/fulltext?referrer=https%3A%2F%2Fwww.gastrojournal.org%2F |
Files
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
(2.7 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation
(2014)
Journal Article
Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search